期刊文献+

2型糖尿病患者尿白蛋白排泄率与补体C5a的关系 被引量:3

The relationship between complement C5a and UAER in type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨2型糖尿病患者血、尿补体活化片段C5a含量的变化与糖尿病肾病的关系。方法选2型糖尿病患者39例,健康体检者21名作为对照,检测血、尿C5a浓度以及血高敏C反应蛋白,测定尿白蛋白排泄率以及血糖控制情况,分析其关系。结果与对照组比较,2型糖尿病患者尿C5a浓度升高(11.4±21.1 vs 76.3±144.4,P<0.05),血C5a无明显变化,尿C5a与尿白蛋白排泄率正相关(r=0.378,P<0.05),糖尿病病程、尿C5a是尿白蛋白排泄率的独立预测因素。结论补体活化可能与糖尿病肾病的发生有关。 Objective To investigate the relationship between complement CSa and diabetic nephropathy. Methods The concentration of plasma CSa and urine CSa was examined in 39 patients with type 2 diabetes mellitus, 21 healthy volunteers as controls. The relationship between complement CSa and UAER was analyzed. Resuts Urinary level of CSa was higher in the diabetic nephropathy group than in control (76. 3±144. 4 vs 11.4±21. 1, P=0. 046), Urinary CSa was positively correlated with UAER. The diabetic course and urinary CSa were the independent predictors of urine albumin excretion rate (UAER) (r = 0. 378, P = 0. 023). Conclusion The activation of complements might involve in the pathogenesis of diabetic nephropathy.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第4期266-269,共4页 Chinese Journal of Diabetes
关键词 糖尿病 2型 尿白蛋白排泄率 C5A Diabetes mellitus, type 2 Urine albumin excretion rate C5a
  • 相关文献

参考文献8

  • 1邱明才,孟春梅.糖尿病并发症发病过程中的补体活化作用[J].中华内分泌代谢杂志,2006,22(3):303-305. 被引量:14
  • 2Uesugi N, Sakata N, Nangaku M, et al. Possible mechanism for medial smoothmuscle cell injury in diabeticnephropathy: Glyeo- xidation-mediated local complement activation. Am J Kidney Dis,2004, 44: 224-238.
  • 3Acosta J, Hettinga J, Fluckiger R, et al. Molecular basis for a link between complement and the vascular complications of dia- betes. PNAS, 2000, 97: 5450-5455.
  • 4马西文,刘永铭,赵丽,薛芙珍,尚东亚.2型糖尿病患者补体调节蛋白CD55、CD59水平的变化及其意义[J].中国糖尿病杂志,2007,15(12):740-741. 被引量:6
  • 5齐洁 朱锡华.补体C5a对中性粒细胞和肾小球内皮细胞粘附行为的影响[J].免疫学杂志,1997,:155-155.
  • 6Uesugi N, Sakata N, Nangaku M, et al. Possible mechanism for medial smoth muscle cell injury in diabetic nephropathy: Glyeoxidation-mediated local complement activation. Am J Kidney Dis,2004,44:224-238.
  • 7Fujita T, ohi H, Kornatsu K, et al. Complement activation accelerates glomerular injury in diabetic rats. Nephron, 1999,81.. 208 214.
  • 8Morita Y, Ikeguchi H, Nakamura J, et al. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol, 2000,11 : 700-707.

二级参考文献32

  • 1刘永铭,严祥,刘艳英.补体与动脉粥样硬化[J].中华心血管病杂志,2005,33(9):866-869. 被引量:21
  • 2刘永铭,何津春,杨京港,刘艳英,严祥,赵丽,马西文,尚东亚,乔成栋,李维辛,王金羊.阿托伐他汀对高脂血症患者补体调节蛋白CD55、CD59表达的影响[J].中华心血管病杂志,2005,33(12):1075-1079. 被引量:15
  • 3Bezaquen LR, Nicholson-Wellor A, Helperin AJ. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-dorived growth factor from endothelial cells. J Exp Med, 1994,179:985-992.
  • 4Wagner C, Braunger M, Beer M, et al. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephro, 1994,2:51-56.
  • 5Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis, 1993,22:736-744.
  • 6Poduslo JF, Curran GL, Dyck PJ. Increase in albumin, IgG and IgM blood-nerve barrier indices in human diabetic neuropathy. Proc Natl Acad Sci USA, 1988,85:4879-4883.
  • 7Younger DS, Rosoklija G, Hays AP, et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve, 1996,19:722-727.
  • 8Graham AR, Johnson PC. Direr immunofluorescence findings in peripheral nerve from patients with diabetic neuropathy. Ann Neurol,1985,17:450-454.
  • 9Muller-Eberhard HJ. The membrane attack complex of complement.Annu Rev Immuno, 1986,4:503-528.
  • 10Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem, 1988,57:321-347.

共引文献18

同被引文献17

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部